Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Daiichi Sankyo
US Army
Julphar
Fish and Richardson
Federal Trade Commission

Generated: May 19, 2019

DrugPatentWatch Database Preview

ULTRAM Drug Profile

« Back to Dashboard

When do Ultram patents expire, and when can generic versions of Ultram launch?

Ultram is a drug marketed by Janssen Pharms and Valeant Pharms and is included in two NDAs. There is one patent protecting this drug and three Paragraph IV challenges.

The generic ingredient in ULTRAM is tramadol hydrochloride. There are thirty-six drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the tramadol hydrochloride profile page.

Drug patent expirations by year for ULTRAM
Pharmacology for ULTRAM
Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for ULTRAM
Synonyms for ULTRAM
(1RS,2RS)-2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-cyclo-hexanol
(1RS,2RS)-2-dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexanol
1-(m-Methoxyphenyl)-2-(dimethylaminomethyl)cyclohexane-1-ol
2-((Dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexan-1-ol
2-[(DIMETHYLAMINO)METHYL]-1-(3-METHOXYPHENYL)CYCLOHEXAN-1-OL
2-[(Dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
2-Dimethylaminomethyl-1-(m-methoxyphenyl)cyclohexanol
2914-77-4
AC1L1KJ8
AC1Q7AST
ACM2914774
AKOS022507395
AN-32783
CHEBI:75722
CHEMBL1237044
COR0000099
CTK4G2807
Cyclohexanol, 2-(dimethylaminomethyl)-1-(m-methoxyphenyl)-
Cyclohexanol, 2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-
Cyclohexanol,2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)-
EINECS 220-831-4
GTPL8286
L000985
LS-57112
LS-57113
LS-57114
Maxitram
MCULE-1882520267
SCHEMBL57496
Tilodol
TVYLLZQTGLZFBW-UHFFFAOYSA-N

US Patents and Regulatory Information for ULTRAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms ULTRAM tramadol hydrochloride TABLET;ORAL 020281-002 Mar 3, 1995 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Pharms ULTRAM ER tramadol hydrochloride TABLET, EXTENDED RELEASE;ORAL 021692-002 Sep 8, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Janssen Pharms ULTRAM tramadol hydrochloride TABLET;ORAL 020281-001 Mar 3, 1995 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Valeant Pharms ULTRAM ER tramadol hydrochloride TABLET, EXTENDED RELEASE;ORAL 021692-001 Sep 8, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Valeant Pharms ULTRAM ER tramadol hydrochloride TABLET, EXTENDED RELEASE;ORAL 021692-003 Sep 8, 2005 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for ULTRAM
Drugname Dosage Strength RLD Date
➤ Subscribe Extended-release Tablets 300 mg ➤ Subscribe ➤ Try a Free Trial
➤ Subscribe Extended-release Tablets 200 mg ➤ Subscribe ➤ Try a Free Trial
➤ Subscribe Extended-release Tablets 100 mg ➤ Subscribe ➤ Try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Army
Citi
Fuji
Teva
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.